CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 117 filers reported holding CUREVAC N V in Q3 2021. The put-call ratio across all filers is 2.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,819 | -51.0% | 10,076 | -25.3% | 0.00% | – |
| Q2 2023 | $140,577 | +64.8% | 13,491 | +10.2% | 0.00% | – |
| Q1 2023 | $85,299 | +3.1% | 12,238 | -10.8% | 0.00% | – |
| Q4 2022 | $82,774 | +29.3% | 13,727 | +67.7% | 0.00% | – |
| Q3 2022 | $64,000 | -48.4% | 8,186 | -10.4% | 0.00% | – |
| Q2 2022 | $124,000 | -61.6% | 9,140 | -44.5% | 0.00% | – |
| Q1 2022 | $323,000 | -94.6% | 16,469 | -90.5% | 0.00% | -100.0% |
| Q4 2021 | $5,946,000 | -68.9% | 173,292 | -50.6% | 0.00% | -72.7% |
| Q3 2021 | $19,147,000 | -32.9% | 350,538 | -9.7% | 0.01% | -35.3% |
| Q2 2021 | $28,526,000 | +12578.2% | 388,227 | +15649.6% | 0.02% | – |
| Q1 2021 | $225,000 | +316.7% | 2,465 | +270.7% | 0.00% | – |
| Q4 2020 | $54,000 | +980.0% | 665 | +565.0% | 0.00% | – |
| Q3 2020 | $5,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 3,134,780 | $286,707,000 | 46.92% |
| Ally Bridge Group (NY) LLC | 110,000 | $10,061,000 | 1.93% |
| Parametrica Management Ltd | 44,695 | $3,968,000 | 1.91% |
| Renaissance Capital LLC | 123,983 | $11,339,000 | 1.68% |
| Samsara BioCapital, LLC | 95,318 | $8,718,000 | 1.61% |
| Ikarian Capital, LLC | 360,000 | $32,925,000 | 1.11% |
| SECTOR GAMMA AS | 25,000 | $2,287,000 | 0.42% |
| Fosun International Ltd | 50,000 | $4,438,000 | 0.35% |
| Ikarian Capital, LLC | 100,000 | $9,145,000 | 0.31% |
| Baillie Gifford | 5,830,101 | $533,221,000 | 0.30% |